SNF472 Mechanism of Action data published in British Journal of Pharmacology
SNF472 selectively inhibits pathological calcification by binding to hydroxyapatite crystals Palma, Spain and San Diego, USA, 25 June 2020 – Sanifit, a clinical-stage biopharmaceutical company focused… Read More »SNF472 Mechanism of Action data published in British Journal of Pharmacology